North America:
The North America corneal transplant market is driven by a high prevalence of corneal diseases and significant advancements in transplant techniques. The region benefits from a well-established healthcare infrastructure, extensive donor tissue availability, and strong awareness among both patients and healthcare providers. The United States leads the market, supported by advanced...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian